Home » Archive by Category


Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

FibroGen, Inc. Announces Phase 2 Data Supporting Longer-Term Safety And Efficacy Profile Of FG-3019 In Patients With Idiopathic Pulmonary Fibrosis

May 19, 2014 – 5:00 am | Edit Post

Zogenix, Inc. Closes Sale Of SUMAVEL® Dosepro® Migraine Therapy To

May 19, 2014 – 5:00 am | Edit Post

Molecules in Motion: A Profile of Ryan Shenvi

May 19, 2014 – 12:00 am | Edit Post

TSRI Assistant Professor Ryan Shenvi, an alumnus of TSRI’s graduate program, focuses on creating new chemical choreography.

Stem Cell Therapy Shows Promise for MS in Mouse Model

May 19, 2014 – 12:00 am | Edit Post

Work led by the Loring lab at TSRI and the Lane lab at the University of Utah shows that human stem cells can help mice regain mobility after a crippling disease similar to multiple sclerosis.

Special Proteins Guide Immunity Against Bacteria that Employ ‘Glycan Camouflage’

May 19, 2014 – 12:00 am | Edit Post

The findings from the Paulson lab at TSRI and the Cummings lab at Emory shed light on how our immune system works and on potential new directions for antibiotic development.

TSRI Celebrates 22nd Commencement

May 19, 2014 – 12:00 am | Edit Post

The ceremony honored 38 graduating biology and chemistry students and honorary degree recipient Jack E. Dixon, a pioneering biochemist.

Salk Education Outreach program wins AAAS grant

May 18, 2014 – 5:00 pm | Edit Post

LA JOLLA—The Salk Institute’s award-winning Education Outreach program recently earned national recognition when it received a two-year pilot grant through the AAAS’s new National STEM (Science, Technology, Engineering and Math) Volunteer Program. The grant, one of just seven the association awarded, will help bring San Diego-area high school science teachers together with Salk scientists to develop curriculum based on the state-of-the-art research taking place at the Institute.

Study: E-cigs increase ‘superbug’ MRSA resistance

May 18, 2014 – 2:00 pm | Edit Post

Vapors also hurt immune cells, says study by UCSD, VA researchers.

Lumena’s IPO Plans End With Acquisition

May 16, 2014 – 2:43 pm | Edit Post

Lumena Pharmaceuticals Inc. is being snapped up by Irish drugmaker Shire PLC for $260 million, scrapping the San Diego biotech’s plan to raise $75 million in an initial public offering.

Sanford-Burnham hosts Bring It! Playoffs 2014

May 16, 2014 – 2:05 pm | Edit Post
Sanford-Burnham hosts Bring It! Playoffs 2014

Sanford-Burnham hosted the sixth annual Bring It! event at the San Diego Hall of Champions in San Diego, Calif., on Thursday, May 1, 2014, to raise funds for medical research. As in prior years, the event was an incredible success. The evening kicked off with a bang as guests walked down an AstroTurf carpet lined

Read More